技术文章您现在的位置:首页 > 技术文章 > 氯膦酸二钠脂质体清除小鼠肿瘤模型巨噬细胞效果检测

氯膦酸二钠脂质体清除小鼠肿瘤模型巨噬细胞效果检测

更新时间:2025-09-29   点击次数:70次

小鼠肿瘤接种模型,时间一般持续2-3周。如何使用氯膦酸二钠脂质体清除小鼠肿瘤模型巨噬细胞?对于这种时间长的疾病模型,小鼠的状态,小鼠的存活,比清除效果更为重要。两者的平衡或者偏向,需要动态调整。

如下这篇Nature Communications,使用荷兰Liposoma品牌巨噬细胞清除剂氯膦酸二钠脂质体:Clodronate Liposomes&Control Liposomes。小鼠疾病模型:LLC肺癌模型。LLC细胞全称为Lewis肺癌细胞(Lewis Lung Carcinoma),是一种来源于小鼠的肺癌细胞系,常用于癌症研究的动物模型中。它并非人类肺癌的临床分型,而是实验室中用于模拟肺癌生长、转移及药物测试的模型工具。腹腔注射200ul,在肿瘤细胞接种后第7天,11天,15天腹腔注射荷兰Liposoma品牌巨噬细胞清除剂氯膦酸二钠脂质体:Clodronate Liposomes&Control Liposomes(CP-005-005)。


氯膦酸二钠脂质体清除小鼠肿瘤模型巨噬细胞效果检测:

氯膦酸二钠脂质体清除小鼠肿瘤模型巨噬细胞效果检测

a Schematic of clodronate and control liposome treatment of LLC tumor bearing mice. b, c LLC tumor volumes over time (b) and endpoint tumor volumes (c) for WT (n = 6 mice treated with control liposomes (con) and 8 mice treated with clodronate liposomes (clod) and for Mlck210−/− [n = 7 mice treated with control liposomes (con) and clodronate liposomes (clod)]. One WT animal treated with clodronate liposomes died on day 14 post-tumor inoculation and was not included in the final tumor weight graph. dg Quantification (d, f) and FACs plots of Ly6C- (e) liver and (g) tumor macrophages from WT and Mlck210−/− mice after treatment with clodronate and control liposomes (n = 4 mice).


论文信息:

论文题目:PI3Kγ stimulates a high molecular weight form of myosin light chain kinase to promote myeloid cell adhesion and tumor inflammation

期刊名称:Nature Communications

时间期卷:13, Article number: 1768 (2022)

在线时间:2022年4月1日

DOI:doi.org/10.1038/s41467-022-29471-6


  

产品信息:

货号:CP-005-005

规格:5ml+5ml

品牌:Liposoma

产地:荷兰

名称:Clodronate Liposomes&Control Liposomes

办事处:Target Technology(靶点科技)


Liposoma巨噬细胞清除剂Clodronate Liposomes氯膦酸二钠脂质体的材料和方法:

Cell depletion

In other experiments, wildtype female C57BL6 or Mlck210−/− mice in the C57BL6 background bearing LLC tumors (n = 6–8) were treated with daily i.p. injections of 1 mg clodronate or control liposomes (Liposoma Research Liposomes # CP-005-005) in 200 µl on day 7,11 and 15 after tumor inoculation. Tumors dimensions were recorded at regular intervals, typically every 1–2 days. Tumors were excised at 18 days after implantation and tumors, spleens and livers were excised for further analysis by flow cytometry. Alternatively, WT and Mlck210−/− C57Bl6 male mice bearing HPV+ MEER tumors (n = 8–11) were treated with i.p. injections of 100 µg anti-CD8 antibodies (BioXcell In Vivo Plus Clone YTS 169.4, #BE0117) or saline on days 27, 29, 32, 41, and 44 after tumor inoculation. Tumor volumes were measured every 2–3 days. Tumors and spleens were harvested on day 48 after tumor inoculation for flow cytometry analysis.




靶点科技(北京)有限公司

靶点科技(北京)有限公司

地址:中关村生命科学园北清创意园2-4楼2层

© 2025 版权所有:靶点科技(北京)有限公司  备案号:京ICP备18027329号-2  总访问量:350863  站点地图  技术支持:化工仪器网  管理登陆